What Sildenafil Farmoz Treats: Main Uses and Benefits

Sildenafil is an active substance that may be part of symptomatic management across two distinct therapeutic domains. This medication is commonly used to help with conditions characterized by periods of heightened symptoms.

The primary application is applied in addressing erectile dysfunction (ED), a condition where functional stability becomes affected. Sildenafil assists with maintaining functional stability, providing support during symptomatic periods. The compound is also used for managing pulmonary arterial hypertension (PAH), a condition marked by increased physiological stress. This covers the broad spectrum of symptoms that interfere with daily functioning and symptoms that create noticeable physiological strain.

The medicine's role is particularly relevant in clinical scenarios involving recurrent or episodic manifestations. Its supportive properties are categorized as follows:

“The medicine's supportive properties are relevant for easing distress and maintaining stability.”

For this universal condition frame, the medicine contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

Quick Fact: Relief for Physiological Strain
Sildenafil is considered relevant for easing symptoms related to systemic imbalance in conditions where short-term symptomatic assistance is needed, supporting patients during periods of heightened discomfort.

Regulatory References

1. NIH MedlinePlus overview

Sildenafil Farmoz, which contains the active substance sildenafil, is primarily indicated for the treatment of erectile dysfunction in adult men and, in some formulations, for pulmonary arterial hypertension (PAH) in adults and children.

Most healthy adult men over 18 can use the medication for erectile dysfunction, provided they have no contraindications. However, its use is strictly contraindicated and should be avoided by several groups of individuals.

---

Contraindications and Caution

Sildenafil Farmoz must not be used by individuals taking any form of nitrate medicine (such as nitroglycerin or isosorbide dinitrate) for chest pain or heart problems, or those taking riociguat (a soluble guanylate cyclase stimulator) for PAH. Combining sildenafil with these medicines can cause a sudden and dangerously low drop in blood pressure.

---

Caution is advised, and a doctor must be consulted before use if you have certain medical conditions. These include:

• Cardiovascular issues: Recent heart attack or stroke (within the last 6 months), uncontrolled high or low blood pressure, life-threatening irregular heartbeat, or if sexual activity is medically inadvisable due to heart problems.
• Eye disorders: Rare inherited eye diseases like retinitis pigmentosa, or a history of non-arteritic anterior ischemic optic neuropathy (NAION) leading to vision loss.
• Other conditions: Severe liver or kidney impairment, blood cell disorders (like sickle cell anaemia or multiple myeloma) which can increase the risk of a prolonged erection (priapism), or anatomical deformation of the penis (such as Peyronie's disease).

Interactions with other medicines and products

The use of Sildenafil Farmoz is subject to specific constraints based on its officially documented interactions with other medicinal products. These interactions fall into categories of absolute contraindication, combinations requiring caution, and combinations that are not recommended.

Interaction Classification	Interacting Agents
Contraindicated Combinations	Nitric oxide donors (e.g., amyl nitrite) and organic nitrates/nitrites in any form, due to potentiation of hypotensive effects. Guanylate cyclase (GC) stimulators (e.g., Riociguat), which may lead to symptomatic hypotension.
Use Not Recommended	Other Phosphodiesterase type 5 (PDE5) inhibitors or other treatments for the same condition, as safety and efficacy data are lacking. Co-administration with Ritonavir is not advised.

Co-administration with strong Cytochrome P450 (CYP) 3A4 inhibitors (e.g., Ketoconazole, Itraconazole, Erythromycin, Saquinavir) results in reduced Sildenafil clearance, significantly increasing its plasma concentration; a lower starting dose should be considered in these cases. Caution is advised when used concomitantly with alpha-blockers, as this may lead to symptomatic hypotension, which is most likely to occur within four hours of dosing. To minimize this risk, patients should be hemodynamically stable on alpha-blocker therapy before beginning treatment.

Sildenafil Farmoz works by selectively intervening in a specific molecular cascade that regulates blood vessel relaxation and tone. The mechanism is specific, modulating the chemical signals that govern smooth muscle activity in defined vascular beds.

Targeting the PDE5 Enzyme and cGMP Amplification

Sildenafil is a selective inhibitor of the enzyme Phosphodiesterase type 5 (PDE5), which is widely present in vascular smooth muscle cells. By blocking PDE5, the drug prevents the rapid breakdown of the chemical messenger cyclic Guanosine Monophosphate (cGMP). This preservation of cGMP levels leads to amplification of the natural signaling for smooth muscle relaxation.

Mechanism Dependence on Nitric Oxide (NO) Pathway

The drug's mechanism operates strictly within the Nitric Oxide (NO)-cGMP pathway and is entirely conditional. Sildenafil is not a direct muscle relaxant; it only becomes active when the body releases NO (e.g., following physiological stimuli). The increase in cGMP sustained by the drug causes the surrounding blood vessels to dilate (vasodilation), which increases blood flow and reduces vascular resistance in the target area.

Sildenafil is used according to distinct protocols depending on the condition being addressed: either Erectile Dysfunction (ED) or Pulmonary Arterial Hypertension (PAH). The medicine is primarily administered via the oral route as a film-coated tablet or suspension. The intravenous (IV) route is reserved for PAH patients who are temporarily unable to take the oral forms, with the IV dose set at 10 mg, which is equivalent to the effect of a 20 mg oral dose.

For ED, the usage follows an intermittent, as-needed schedule. The typical starting dose is 50 mg, which may be adjusted within a range of 25 mg to a maximum of 100 mg once per day. This intermittent use pattern means the medicine is not taken daily.

Conversely, the use protocol for PAH is a fixed, chronic regimen. The oral dose is typically 20 mg taken three times a day (TID), with doses separated by approximately four to six hours, and may be adjusted up to 80 mg TID. Both oral forms can be taken with or without food. Special procedural conditions apply to some patients; for instance, a starting dose of 25 mg is considered for ED in older adults (over 65 years) or those with severe renal or hepatic impairment. If a scheduled PAH dose is missed, the standard procedure is to take it as soon as possible and resume the normal schedule, without taking a double dose.

Sildenafil Farmoz: Recent Clinical Evidence

---

Evidence for use in Erectile Dysfunction (ED)

Research into erectile dysfunction has primarily involved Randomized Controlled Trials (RCTs) against a placebo control. These studies monitored functional success, including the ability to achieve and maintain an erection adequate for intercourse, using standardized patient-reported outcomes. Findings describe patterns observed in these short-term trials in adult men whose diagnoses aligned with the research protocols. A limitation is that the long-term functional outcomes and patterns of change over extended periods are not fully established by the initial pivotal trials.

---

Evidence for use in Pulmonary Arterial Hypertension (PAH)

The evidence base for PAH, a condition marked by functional limitations, was evaluated in pivotal Randomized, Placebo-Controlled Trials. These studies monitored functional measures, such as the 6-Minute Walk Distance (6MWD), which reflects daily functioning or activity level. Researchers also tracked outcomes like the time to a clinical worsening event. The research describes how functional capacity evolved, reporting measurements of the distance walked and patterns related to clinical stability.

---

Evidence in Special Populations

Research has explored the substance in studies involving certain specific groups, notably the pediatric population (children aged 1 to 17 years) for the PAH indication. Data for certain groups are limited, and the research exploring physiological imbalance in children with PAH has described varying patterns across different studies. These subgroup findings are uncertain, highlighting that outcomes in this specific group remain an active area of investigation.

---

Research Limitations and Uncertainty

Across both indications, key limitations exist. Direct comparative evidence against all other options is not available in certain areas, meaning the substance has not always been directly compared against all alternatives in head-to-head trials. Furthermore, evidence quality varies, and certainty remains low in the specific functional outcomes for certain special populations, such as the pediatric group for PAH, where data are still emerging.

Key Studies & References

1. Sildenafil Use in Pulmonary Arterial Hypertension (SUPER-1 Study) (Pivotal adult PAH trial, 6MWD outcome)

Common questions about Sildenafil Farmoz (FAQ)

---

Q: Is Sildenafil Farmoz the same medicine as Viagra, based on its active ingredient?

Sildenafil is the active substance contained in Sildenafil Farmoz. This substance is also the active ingredient used in the brand-name medicine Viagra. Official regulatory reviews have determined that generic products containing Sildenafil, like Farmoz, are bioequivalent to the original brand.

Q: Is the onset of action different for older individuals using Sildenafil Farmoz?

Official prescribing information indicates that for healthy elderly volunteers (aged 65 and over), the clearance of Sildenafil is reduced compared to younger adults. This results in higher levels of the drug remaining in the body's system (systemic exposure). Because of this pharmacological observation, healthcare providers may consider a lower starting dose for older patients.

Q: Is Sildenafil Farmoz appropriate for someone with a diagnosed heart condition?

Regulatory documents specify that Sildenafil Farmoz is strictly contraindicated (should not be used) if you are taking nitrates or riociguat, or if you have a recent history of a stroke or heart attack. Beyond these absolute restrictions, the appropriateness of the medicine depends on an assessment of your overall cardiovascular health. The official position is that use is appropriate only when your healthcare provider has determined that sexual activity itself is medically safe.

Q: What age range is generally described as eligible to use Sildenafil Farmoz?

The official indications state that the medicine is used for treating erectile dysfunction in adult men and for Pulmonary Arterial Hypertension in adults and children.

Q: What happens if a person misses a planned use of Sildenafil Farmoz?

The regulatory guidance depends on the regimen being used. For the 'as-needed' schedule (Erectile Dysfunction), the concept of a missed dose is not applicable. For the fixed, chronic regimen (Pulmonary Arterial Hypertension), official guidance describes a specific action to be taken, which generally involves resuming the normal schedule and avoiding a double dose.

Q: Is it possible for women or children to use Sildenafil Farmoz for an approved condition?

Yes, regulatory documents state that Sildenafil is indicated for the treatment of Pulmonary Arterial Hypertension (PAH) in both women and children. It is important to note that the medicine is not indicated for women for the treatment of Erectile Dysfunction, which is a condition specific to adult men.

Q: Which organs in the body are primarily responsible for processing Sildenafil Farmoz?

The medicine is primarily processed, or metabolized, by certain enzymes located in the liver. Following this process, the substance and its breakdown products are primarily removed from the body as metabolites in the feces. A lesser amount is eliminated through the urine (kidneys).

Q: How long does the effect of Sildenafil Farmoz typically take to be observed?

Official pharmacokinetic studies indicate that the maximum concentration of the medicine in the blood plasma is generally reached between 30 and 120 minutes after it is taken. The median time to reach this peak is about one hour when the medicine is consumed without food.

Q: What is the general duration of effect described for Sildenafil Farmoz?

Official information describes the terminal elimination half-life for Sildenafil and its primary active metabolite as approximately four hours. This figure relates to the time it takes for the concentration of the substance in the body to be reduced by half.

Q: Is there a described interaction between Sildenafil Farmoz and alcohol consumption?

Sildenafil is known to have properties that widen blood vessels (vasodilation), which can lead to a mild decrease in blood pressure. The consumption of alcohol may potentially enhance this effect, or additive blood pressure lowering effects may occur. This additive effect may increase the potential for experiencing symptoms such as lightheadedness or dizziness.

Q: Is the consumption of grapefruit or grapefruit juice relevant to using Sildenafil Farmoz?

Yes, the consumption of grapefruit juice may be relevant because it can inhibit the enzyme responsible for breaking down Sildenafil in the body. This interaction may result in higher concentrations of the medicine in the bloodstream. Official counseling materials note that consumption of grapefruit juice is generally discouraged, especially when Sildenafil is used for the Pulmonary Arterial Hypertension (PAH) indication.

Q: Does Sildenafil Farmoz have any documented post-market surveillance data?

Official regulatory labels include data from post-marketing surveillance, which collects information after the medicine is made available to the public. This surveillance has documented reports of rare but serious adverse reactions, including conditions like Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) and cases of sudden hearing loss.

Q: Is Sildenafil Farmoz considered a medicine that carries a risk of dependence?

Sildenafil is not classified as a controlled substance by regulatory agencies. Furthermore, official documentation does not include information indicating that the medicine carries a risk of physical dependence or abuse potential.

Q: Does Sildenafil Farmoz have any known impact on fertility?

Studies involving healthy male volunteers have examined the potential impact on reproductive factors. The findings from these studies indicated that there was no observed effect on either sperm motility or sperm morphology following single doses of the substance.

Q: What types of allergic reactions are documented as possible, though rare, with Sildenafil Farmoz?

Allergic reactions are documented as a potential adverse effect. These may include the development of a rash or swelling of the face, lips, or throat, or difficulty with breathing. Official patient information notes that these or other serious symptoms are warnings that prompt evaluation by a healthcare provider is necessary.

Q: What information is provided about potential overdosage with Sildenafil Farmoz?

Information on potential overdosage indicates that adverse events observed were generally consistent with the known side effect profile of the medicine. However, these events were reported at increased rates and severity. The official recommendation is that standard medical supportive measures are to be considered and implemented by a healthcare professional as clinically appropriate.

Q: What should be done if a potential overdose is suspected?

Regulatory information indicates that in the event of a suspected overdosage, prompt engagement with emergency medical services is warranted. Supportive care is then administered by healthcare professionals as clinically needed.

How to Store and Dispose of Sildenafil Farmoz?

Sildenafil tablets must be stored according to official regulatory requirements to ensure product quality and safety. The medication should be stored at a temperature not exceeding 30 C and must be kept in the original package to protect it from moisture.

It is a mandatory safety requirement to keep this medicine out of the sight and reach of children.

For disposal, do not throw away unused or expired tablets via wastewater or household waste. All unused product or waste material must be disposed of in accordance with local requirements. Patients should ask a pharmacist for guidance on proper disposal methods.